Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
- Martee L. Hensley
- , Shreyaskumar R. Patel
- , Margaret von Mehren
- , Kristen Ganjoo
- , Robin L. Jones
- , Arthur Staddon
- , Daniel Rushing
- , Mohammed Milhem
- , Bradley Monk
- , George Wang
- , Sharon McCarthy
- , Roland E. Knoblauch
- , Trilok V. Parekh
- , Robert G. Maki
- , George D. Demetri
- Memorial Sloan-Kettering Cancer Center
- University of Texas MD Anderson Cancer Center
- Stanford University
- Fred Hutchinson Cancer Research Center
- Royal Marsden Hospital
- Ohio State University
- University of Pennsylvania
- Indiana University Bloomington
- University of Iowa
- St. Joseph's Hospital and Medical Center, Phoenix
- Johnson & Johnson
- Icahn School of Medicine at Mount Sinai
- Cold Spring Harbor Laboratory
- Harvard University
Research output: Contribution to journal › Article › peer-review
61
Scopus
citations